Purpose: Up to now, there is no feasible solution for stopping or reversing the degenerative process of osteoarthritis (OA). Our study evaluated the effect of intraarticular injection of growth hormone (GH) in OAinduced rabbit knees compared to hyaluronic acid (HA) and placebo. Materials and Methods: A total of 21 male, skeletally mature, New Zealand rabbits received an intraarticular type II collagenase injection for OA induction. Two weeks later, the rabbits were randomized into three groups based on the weekly intraarticular injection to be received: GH, HA, and saline. Injections were done for three consecutive weeks. Evaluation was done at 8 weeks after treatment, clinically using the lameness period, macroscopically using the Yoshimi score and microscopically using the Mankin score. Results: The shortest period of lameness was found in the GH group (15.9±2.12 days), compared to the HA group (19.4±1.72 days) and placebo group (25.0±2.94 days). There was a statistically significant difference in macroscopic scoring between groups (p=0.001) in favor of the GH group. There was also significant difference in the microscopic score between groups (p=0.001) also in favor of the GH group. Conclusions: Intraarticular injection of GH showed better clinical, macroscopic and microscopic results as compared to HA and placebo. 
Introduction
Osteoarthritis (OA) is the most common form of arthritis which represents a group of synovial degenerative diseases that cause disturbance starting from the cellular level to the extracel lular level 1, 2) . Chronic pain elicited by the disease limits move ment and decreases the patient's quality of life 35) . Many pharmacological agents were trialed to relieve symptoms and alter the degenerated cartilage structure, but none has been proven satisfactory. Currently, the standard conservative treat ment for OA is symptomatic (analgesics), either as monotherapy or in combinations. Hyaluronic acid (HA) is one of the most commonly used pharmacological agents. Studies have shown promising results of intraarticular injection of HA, as it is able to alter the cartilage degeneration by means of chemical and me chanical mechanisms. However, the chondroprotective effect of HA was not proven 4) . Coinjection of HA and recombinant hu man growth hormone (GH) was found more effective in modify ing structures and symptoms when compared to the injections of HA alone in OAinduced rabbits 6) . A new monoendothelial vessel formation (morphoangiogenesis) was found after the con comitant intraarticular injections and is believed as a cartilage regeneration factor in OA 6, 7) . GH is known able to stimulate cell growth, reproduction and regeneration. It is made in the anterior pituitary gland, secreted by somatotropic cells to the blood stream and stimulates insulinlike growth factor1 (IGF1) production by the liver. This IGF1 would Intraarticular Recombinant Human Growth Hormone Injection Compared with Hyaluronic Acid and Placebo for an Osteoarthritis Model of New Zealand Rabbits revealed that morphoangiogenesis found in the knee injected with recombinant human GH played a role in cartilage regeneration.
Although found beneficial, the injection of intraarticular GH is still an 'off label' method because there is not enough evidence about the mechanism of GH in improving cartilage regenera tion. We hypothesized that the sole intraarticular injection of GH is able to improve cartilage regeneration and provide a better outcome when compared to intraarticular injections of HA. We conducted an in vivo clinical trial to examine the benefit of intra articular injection of GH and explored the possibilities for clinical application.
Materials and Methods

Study Design and Subject Selection
We conducted an experimental research with the posttest only control group design at the teaching animal hospital and anatom ic pathology laboratory of faculty of veterinary medicine, Bogor Agricultural University, Indonesia.
As many as 21 skeletally mature male New Zealand rabbits that weigh 2,000 g to 2,500 g free of deformities on all lower limbs were used as subjects. The subjects were acclimatized in a modi fied room temperature ranging 18°C-21°C with humidity of 55% and were given dry food (5 g per 100 g body weight). To reduce experimental bias, randomization of the subjects and blinding to drug preparation and the attending veterinarian responsible for evaluation were done (Fig. 1). 
Preliminary Study and Drug Administration
A preliminary study of OA induction by intraarticular colla genase injections was done. The knee of the hind leg was shaved and disinfected using povidone iodine. Intramuscular injec tion of anesthetic agents, xylazine (1.9 mg/kg body weight) and ketamine (46 mg/kg body weight), was done. Two milligrams of type II collagenase extracted from Clostridium histolyticum (enzyme activity 425 U/mg; SigmaAldrich, St. Louis, MO, USA) was dissolved in 0.5 mL sterile phosphatebuffered saline solution and filtered through a 0.22 µm membrane. The solution was then injected with prefiltered saline phosphate (pH 7.4) to the knee joint. The second injection was done 3 days after the first injec tion. The destruction effect from these injections was expected in 2 weeks after the second injection.
Different treatment was given two weeks after the OA induc tion. Randomization was done and the subjects were divided into three groups in respect of their treatment (placebo, HA, and GH). The injection was done with 1 mL 26G syringe. The HA treatment group was injected with 1 mL (10 mg) of sodium hy aluronate (Osflex; Novell Pharmaceutical Laboratories, Jakarta, Indonesia). The GH treatment group was injected with 1 mL (4 IU) of recombinant human somatropin (Novell Eutropin, Novell Pharmaceutical Laboratories). The placebo group was injected with 1 mL of normal saline. The subjects were then returned to the cage and observed daily for limping gait (lameness) and body weight changes for 8 weeks after the first injection. After 8 weeks, all of the subjects were euthanized using intravenous phenobar bital (10 mg/kg).
Evaluation
After the injection treatment and before the euthanasia, the subjects were clinically observed for lameness period. At 8 weeks after treatment, macroscopic changes were evaluated using structural criteria suggested by Yoshimi et al. 8) . Histopathologic examination was also performed to assess the degree of carti lage changes according to the scoring system of Mankin 9) . After euthanasia, specimens obtained from the lateral condyle of the femur were taken for histopathological examination, decalcified with 20% ethylenediaminetetraacetic acid, and fixed with 10% buffered formalin. Slicing was done for 5 slices (5 mm thick coro nal cuts) and staining using hematoxylineosin was done. Scoring system details are presented in Table 1 .
Statistical Analysis
Statistical analysis was done using IBM SPSS ver. 20.0 (IBM Corp., Armonk, NY, USA), using analysis of variance (ANOVA) test and nonparametric MannWhitney test. Based on the Fe derer formula, the minimum sample size required for the study was 8 samples for each group. However, the ethical clearance committee only allowed us to proceed with the total samples of 21 rabbits. The ANOVA parametric test and MannWhitney nonparametric test were performed to analyze the correlation between study groups. The results were considered statistically significant if pvalue was less than 0.05.
Ethical Clearance
This study obtained ethical approval from the Animal Hospital of Bogor Botanical Institute (RSH IPB) Ethical Committee (no. 022015 RSHIPB).
Results
Induction of Osteoarthritis
A preliminary study was done to evaluate the time needed for type II collagenase to degenerate cartilage tissue of the subject's knee in order to mimic fullblown OA. After two weeks, evalua tion was done macroscopically and microscopically. Destruction of cartilage was evident macroscopically (Fig. 2) , and fissure on the radial zone and hypocellularity of the chondrocytes were evi dent microscopically (Fig. 3) ; thus, confirming the characteristics of OA.
Evaluation of Lameness Period
The longest lameness period was observed in the control group (mean, 25 days) with the shortest lameness period found in the GH group (mean, 15.9 days), and the HA group's lameness pe riod was found in between (mean, 19.4 days). Significant differ ence was found between the control, HA group and GH group (p<0.001), the HA group and the control group (p=0.001), the control and GH group (p<0.001) and the HA group and GH group (p=0.030) ( Table 2 ).
Evaluation of Macroscopic Parameters after 8 Weeks of Treatment
For macroscopic evaluation, the Yoshimi scoring system was used (Tables 3, 4 ). According to the SaphiroWilk test, the Yoshi mi score from the control group and HA group showed a normal data distribution (p=0.062 and p=0.086), meanwhile the Yoshimi score from the GH group did not have a normal data distribution 8, 9, 14, 18, 27) Lameness period to evaluate clinical changes: the time required by the rabbit to be able to hop normally again (using both of its hind legs) since the induction of osteoarthritis The KruskalWallis test showed a statistically signifi cant difference for Yoshimi score between the control, HA group and GH group (p=0.001). Using the mean difference test between two groups, significant difference was found between the control group and the HA group (independent ttest, p=0.004), the con trol and GH group (MannWhitney test, p=0.001), and the HA group and GH group (MannWhitney test, p=0.040) (Fig. 4) .
Evaluation of Histopathological Score
A modified Mankin scoring system was used for histopatholog ical evaluation of the subject's cartilage. According to the Saphiro Wilk test, the Mankin score from the control and GH group had a normal data distribution (p=0.609 and p=0.086, respectively), and HA group did not have a normal data distribution (p<0.05). The KruskalWallis test found a statistically significant difference between the control, HA group and GH group in favor of the GH group (p=0.001). Significant difference was found between the control and GH group (p=0.001), HA group and GH group (p=0.015) and control and HA group (p=0.020) ( Tables 5, 6 ).
Correlation between Yoshimi Score and Mankin Score
Spearman analysis found that there was a significant strong cor relation (r=0.768) between the Yoshimi score and Mankin score (p<0.001). 
Discussion
Our study hypothesized that sole intraarticular injection of GH would be able to improve cartilage regeneration and provide a better outcome when compared to intraarticular injections of HA. The end result of this study found that GH injection is able to aid cartilage regeneration and is proven clinically, microscopi cally and macroscopically better than HA injection.
Subject Selection
In this study we used white New Zealand rabbits because the subjects have similar anatomy with human cartilage and are easy to maintain and handle during treatment at an affordable cost. Male rabbits were chosen because they have higher survival rates A B C than females. Rabbits with a minimum age of 7-8 months were chosen to ensure skeletal maturity, which occurs at 6 months of age. The weight of the rabbits in our study ranged from 1,900 g to 2,500 g, in which the amount of knee joint synovial fluid is equal to 0.8-1.0 mL 6) .
Fig. 4. Macroscopic appearance of the femoral condyle joints in three different treatment groups: control group (A), hyaluronic acid group (B), and growth hormone group (C). We can still see ulceration (arrows) (A), erosion of cartilage (arrows) (B), and softened cartilage (arrows) (C).
OA Induction on the Knee Joint
In this study, we chose collagenase clostridium hystolyticum type II (SigmaAldrich), a proteolytic enzyme, to induce OA on the rabbit's knee. It causes damage on the articular cartilage through the breakdown of the collagen and glycosaminoglycan, the main composition of cartilage matrix structure 10, 11) . This method was first used by Chu et al. 12) : they used various dosages and time intervals and concluded that the optimum dose to induce knee OA was 2 mg with a 3day interval. Some studies found that there would be no regeneration or sign of healing of the rabbit's cartilage within two weeks up to twelve weeks after the injec tion 6, 10, 11, 13) . Inducing OA chemically using the proteolytic enzyme is superior for analyzing the pathology of articular cartilage com pared to other techniques such as meniscectomy and anterior cruciate ligament resection because it mimics the natural process of OA in humans 6, 7, 13) . Collagenase can be reproduced better than papain 10) and nonsurgical method is easier to use with lower cost and produce better survivability of rabbits.
Clinical Effect of Growth Hormone
Joint pain is the main parameter in evaluating the outcome of OA therapy 6, 14) . The pain may be caused by the cartilage de fect and various inflammation factors, triggering limping gait (lameness) on the subjects. After the treatment, we found the lowest lameness period was in the GH group (15.9±2.12 days), compared to the HA group (19.4±1.72 days) and placebo group (25.0±2.94 days). Although this finding is similar to the study done by Kim et al. 6) , the lameness period was longer than that in The cartilage surface is irregular (arrow) on ×100 magnification. Evidence of more damage is seen with hypocellularity (C; ar rows) and radial zone tearing (D; arrow) on ×100 magnification.
other studies 15) . Injection of GH as a single agent does not have mechanical ef fect or local antiinflammatory effect at the joint 8, 16) . The effect of GH in overcoming inflammatory pain is through the indirect role of cortisol and IGF1 which suppress the inflammatory process and prostaglandin that act as the pain mediator 14, 17) . The assessment of pain scale in this study was highly dependent on the observer. However, we minimized the bias by using a blind evaluation method. Gibson and Donnelly 18) found that observa tion of lameness period in rabbits has low reproducibility and a high inter and intraobserver variability.
Macroscopic and Microscopic Evaluation of Cartilage
Microscopic and macroscopic assessment of cartilage is the best method to quantify the level of damage caused by the process of OA and its healing. The significant differences in Yoshimi scores between treatment groups in our study indicate that the healing process was better in the GH group and GH may have a positive effect for OA of the knee when compared to HA. This finding is similar to the study by Kim et al. 6) even though they compared the combination of HA with GH to HA and placebo 19) . Our study used a modified Mankin scoring system for its good accuracy, high intra and interobserver reproducibility, and easiness to use 6, 20, 21) . Significant differences in scoring between the groups with GH group showing the best score are similar to those in other studies that found the healing of the cartilage can occur after the intraarticular injection of GH 6, 8, 15) . Although the mechanism of regeneration of cartilage after the injection of GHs is not fully understood, Dunn 7) discovered a process of neovascu larization, wherein there are layers of neocapillary blood vessels that penetrate the bone layer. This morphoangiogenesis process is important in producing stem cells that eventually play a role in the regeneration of cartilage. Additionally, our histopathologi cal examination found a form of glomeruloid in the GH group, which is characterized as fenestrated small arteries. This structure was not found in the placebo group and HA group (Fig. 5, 6 ). According to Iwamoto et al. 15) , GH affects chondrocytes indi rectly through the function of IGF1, stimulating them to be active and proliferate. This finding was also supported by Kolbeck et al. 22) . Hypercellularity of the knee cartilage histologically was also found higher in the GH group than other groups meaning that healing may have taken place in the GH group (Fig. 7) .
Intermediateweight HA (1.2×10 6 Da) with 3× injections was used as a comparison to GH due to its properties that needed 3-5 times of injection to mimic the dose that we used for intra articular GH injections 23) . Lower molecular weight HA is easier to inject to the narrow knee of the rabbit because it is less viscous than the high molecular weight HA. We injected 6 mg HA using 26G similar to the research done by Mihara et al. 19) and Kobayas hi et al. 24) where the use of different molecular weight HA showed a synergistic effect. Various literatures exposed controversies between the use of low molecular HA and high molecular HA in OA. Yoshimi et al. 8) and Brockmeier and Shaffer 25) stated that high molecular HA delivers better results than low molecular HA 16) while Atay et al. 26) , and Kotevglu et al. 23) reported that there are no significant differences in the case of intraarticular HA in jection for OA. Based on our findings, we conclude that the GH provides a better effect than placebo and HA for osteoarthritic joints. The pathophysiology of healing may be related to the new vascular structures that were found in the microscopic evaluation. Re gardless of the positive findings, our study has some inevitable limitations and further research may be necessary. This study might have shown better results if it fulfilled the adequate sample size; although the calculated minimum sample size was 24, our Animal Ethical Committee approved only 21 samples. In addi tion, we only evaluated a single dose of GH (4 IU); perhaps the use of various doses would help determine the optimal dose of GH for the best result. Longer evaluation time may also a good point to explore further in order to have an insight for longterm results or possible side effects.
Conclusions
Intraarticular injection of GH as a single agent gives a better result in terms of clinical, macroscopic and microscopic findings in New Zealand rabbits with knee OA, serving as a possible alter native for treatment of OA. However, more research still needs to be done on the optimal GH dose, longterm results, GH serum level measurement and any possible side effects.
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